- Home
- ACRE vs SLRN Comparison
ACRE vs SLRN Comparison
Compare ACRE & SLRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRE
- SLRN
- Stock Information
- Founded
- ACRE 2011
- SLRN 2020
- Country
- ACRE United States
- SLRN United States
- Employees
- ACRE N/A
- SLRN N/A
- Industry
- ACRE Real Estate Investment Trusts
- SLRN Biotechnology: Pharmaceutical Preparations
- Sector
- ACRE Real Estate
- SLRN Health Care
- Exchange
- ACRE Nasdaq
- SLRN Nasdaq
- Market Cap
- ACRE 337.1M
- SLRN 309.0M
- IPO Year
- ACRE 2012
- SLRN 2023
- Fundamental
- Price
- ACRE $5.91
- SLRN $1.99
- Analyst Decision
- ACRE Hold
- SLRN Hold
- Analyst Count
- ACRE 7
- SLRN 5
- Target Price
- ACRE $6.80
- SLRN $9.60
- AVG Volume (30 Days)
- ACRE 781.8K
- SLRN 1.6M
- Earning Date
- ACRE 02-20-2025
- SLRN 11-13-2024
- Dividend Yield
- ACRE 16.91%
- SLRN N/A
- EPS Growth
- ACRE N/A
- SLRN N/A
- EPS
- ACRE N/A
- SLRN N/A
- Revenue
- ACRE $39,423,000.00
- SLRN N/A
- Revenue This Year
- ACRE N/A
- SLRN N/A
- Revenue Next Year
- ACRE N/A
- SLRN N/A
- P/E Ratio
- ACRE N/A
- SLRN N/A
- Revenue Growth
- ACRE N/A
- SLRN N/A
- 52 Week Low
- ACRE $5.33
- SLRN $1.91
- 52 Week High
- ACRE $10.53
- SLRN $8.89
- Technical
- Relative Strength Index (RSI)
- ACRE 43.41
- SLRN 27.77
- Support Level
- ACRE $5.33
- SLRN $1.96
- Resistance Level
- ACRE $5.99
- SLRN $2.19
- Average True Range (ATR)
- ACRE 0.19
- SLRN 0.25
- MACD
- ACRE 0.03
- SLRN -0.03
- Stochastic Oscillator
- ACRE 65.34
- SLRN 3.92
About ACRE Ares Commercial Real Estate Corporation
Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.
About SLRN ACELYRIN INC.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of of transformative medicines.